Abstract
The cardiovascular and metabolic effects of phenylephrine were investigated in dogs with particular emphasis on correlations with myocardial oxygen (O2) uptake. Phenylephrine could be shown to increase myocardial O2 uptake but only at doses which also caused a significant increase in mean systolic pressure (MSP). The myocardial O2 uptake was always strongly correlated with the product of MSP and heart rate (HR) in these dogs both before and during infusion of the drug. Reflex bradycardia, which accompanied the rise in MSP, probably had the effect of limiting myocardial O2 uptake. This was established, in part, by infusion of drug in vagotomized animals with fixed HR and in animals in which the vagus was stimulated directly. The cardiovascular effects of phenylephrine were also accompanied by hyperglycemia, but the plasma levels of nonesterified fatty acids were not changed. The results of these experiments suggest that phenylephrine causes increased myocardial O2 uptake only in proportion to increased cardiac work and therefore is not an O2-wasting sympathomimetic amine.
Footnotes
- Received August 17, 1966.
- Accepted November 11, 1966.
- © 1967 by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
